Financial Trends -- 4/10
Financial trends are dominated by the ~$35B Ansys acquisition (closed July 2025). Strip the inorganic
boost and the picture is mixed-to-soft: headline revenue accelerates (+41.9% latest quarter) but the
inflection is entirely Ansys consolidation, GAAP operating margin compressed ~910bps (22.1% to 13.0%
FY25) and GAAP operating income FELL 32% even as revenue rose 15%, and the stock-funded deal diluted
shareholders ~23% while loading ~$13.5B of debt onto a formerly net-cash balance sheet. Genuine positives:
a resilient ~37% non-GAAP operating margin, intact ~77-80% gross margins, and positive, growing free
cash flow (~$1.35B FY25 toward ~$1.9B guided FY26). Two mandatory penalty modifiers applied.
Weight: 25%
GAAP Op Margin
Compressing
~-910bps FY25 | Ansys amortization
FCF
Growing
$1.35B FY25 to ~$1.9B guided | Bright spot
Share Count
Diluting
~+23% YoY | Ansys stock issuance
Quarterly Revenue Trajectory ($M)
Headline acceleration is inorganic.
The sharp inflection from F25Q4 onward (+37.8% to +65.5%) is entirely Ansys consolidation, not
organic demand. Organic core EDA growth is high-single/low-double digit and roughly stable; core
Design IP went negative YoY for two straight quarters before recovering. Per investing principles,
revenue growth alone is not a financial strength -- the M&A-driven top line must be read net of the
margin compression, dilution, and leverage the deal created.
Margin Compression -- GAAP vs Non-GAAP (Annual)
GAAP operating income FELL 32% while revenue rose 15% -- the textbook
"revenue growing but operating income declining" red flag. GAAP operating margin collapsed
from a 22.1% FY24 peak to 13.0% FY25 (-910bps), driven by Ansys amortization, acquisition, and
restructuring charges, and sits at just 5.3% in the latest quarter. Non-GAAP held up far better
(-120bps to 37.3%), and the latest quarter's 39.5-42.1% shows the underlying franchise is intact --
but even non-GAAP is flat-to-modestly-down, not expanding.
Annual Financial Summary (FY ends October 31)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total Revenue ($M) | $4,204.2M | $5,081.5M | $5,842.6M | $6,127.4M | $7,054.2M |
| Rev YoY | — | +20.9% | +15.0% | +4.9% | +15.1% |
| Gross Margin % | 79.5% | 79.1% | 79.1% | 79.7% | 77.0% |
| Non-GAAP Op Margin | 30.5% | 33.0% | 35.1% | 38.5% | 37.3% |
| Non-GAAP Dil. EPS | $6.84 | $8.90 | $11.19 | $13.20 | $12.91 |
| Non-GAAP EPS YoY | — | +30.1% | +25.7% | +18.0% | -2.2% |
| Diluted Shares (000) | 157,340 | 156,485 | 155,195 | 155,944 | 165,656 |
| Long-term Debt ($M) | $25.1M | $20.8M | $18.1M | $15.6M | $13,462.4M |
Note on GAAP EPS quality. FY24 GAAP net income/EPS was inflated
by a large one-time divestiture gain (Software Integrity sale), so FY25 GAAP falling despite revenue
growth is partly an artifact of a poor-quality comparison. The clean read is non-GAAP: EPS compounded
strongly through FY24 ($6.84 to $13.20) before dipping -2.2% in FY25 to $12.91 as Ansys integration
and dilution weighed.
Key trends
- Revenue compounding, but FY25 acceleration is inorganic: $4.2B (FY21) to $7.1B (FY25); the headline +15.1% and the quarterly re-acceleration to +41.9% are Ansys consolidation, not organic demand
- GAAP margins compressing: GAAP operating margin fell ~910bps (22.1% to 13.0%) and GAAP operating income dropped 32% in FY25 on Ansys amortization and deal charges
- Non-GAAP franchise intact: ~77-80% gross margins and ~37% non-GAAP operating margin held up; the latest quarter ran 39.5-42.1%
- Heavy dilution: diluted shares jumped from 155.9M (FY24) to 165.7M (FY25) and to 192.1M in the latest quarter -- roughly +23% YoY from the stock-funded deal
Segment Revenue ($M, Quarterly)
Ansys lands inside the Design Automation segment from F26Q1,
inflating its growth. Design Automation YoY is uninterpretable post-deal (it jumps from
organic to organic+Ansys). The one clean organic signal is Design IP, which went negative for two
consecutive quarters (-7.7%, -6.5%) before recovering to +13.6% -- the transitional IP year that
management flagged.
Free Cash Flow
FCF positive and growing -- the reason this is not a bottom-tier score.
FY25 FCF of $1,350M (~19.1% FCF margin) with management guiding FY26 toward ~$1.9B (OCF ~$2.2B less
~$300M capex), growing both absolutely and as the post-Ansys revenue base ramps. No negative-FCF penalty
applies.
Penalty Modifiers Applied
| Modifier | Detail | Penalty |
|---|---|---|
| Revenue up, Op Income down | FY25 revenue +15.1% while GAAP operating income fell 32% ($1,355.7M to $914.9M) | -1 |
| Share dilution >10% YoY | Diluted shares ~+23% YoY (155.9M to 192.1M) from stock-funded Ansys deal; just under the 25% severe threshold | -1 |
| Negative FCF | N/A -- FCF positive and growing | None |
| Debt > revenue growth 3+ qtrs | N/A -- one-time spike for the deal, now actively declining ($14.3B to $10.0B); net debt/EBITDA ~3.1x | None |
Score Rationale
Base read against the rubric sits around a 6 (headline acceleration + growing FCF, offset by compressing GAAP margins and heavy dilution). Two mandatory penalty modifiers bring it to 4/10: 6 − 1 (revenue up / operating income down) − 1 (share dilution >10% YoY) = 4/10.
Supports the score off the bottom:
- FCF positive and growing (~$1.35B FY25 toward ~$1.9B guided FY26)
- Resilient ~37% non-GAAP operating margin and intact ~77-80% gross margins
- Latest quarter's 39.5-42.1% non-GAAP margin shows the underlying franchise is intact
Drags the score below average:
- Headline revenue acceleration is M&A-driven, not organic
- GAAP operating margin compressed ~910bps and GAAP operating income fell 32% while revenue rose 15%
- ~23% share dilution from the stock-funded deal
- ~$13.5B of new debt on a formerly net-cash balance sheet; net debt/EBITDA now ~3.1x
Per investing principles -- "revenue growth alone is not a financial strength" -- the combination of compressing GAAP profitability, heavy dilution, and a leveraged balance sheet earns a below-average 4/10. The franchise quality is high, but the current financial trajectory is being weighed down by integration costs and a worse capital structure than 12 months ago.
Data sourced from Daloopa (company_id: 176). Fiscal year ends October 31. All financials in USD. Daloopa labels SNPS by calendar quarter; fiscal labels shown here map calendar 2025Q4 = fiscal 2026Q1.